Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neurology ; 95(14): e1979-e1987, 2020 10 06.
Article in English | MEDLINE | ID: mdl-32732293

ABSTRACT

OBJECTIVE: To assess the clinical course of multifocal motor neuropathy (MMN) in a large cohort of patients and to identify predictive factors of a progressive disease course. METHODS: Between May 2015 and February 2016, we collected clinical data from 100 patients with MMN, of whom 60 had participated in a nationwide cross-sectional cohort study in 2007. We documented clinical characteristics using standardized questionnaires and performed a standardized neurologic examination. We used multiple linear regression analysis to identify factors that correlated with worse outcome. RESULTS: We found that age at diagnosis (45.2 vs 48.6 years, p < 0.02) was significantly increased between 2007 and 2015-2016, whereas diagnostic delay decreased by 15 months. Seven out of 10 outcome measures deteriorated over time (all p < 0.01). Patients who had a lower Medical Research Council (MRC) sumscore and absence of 1 or more reflexes at the baseline visit showed a greater functional loss at follow-up (p = 0.007 and p = 0.016). CONCLUSIONS: Our study shows that MMN is a progressive disease. Although 87% of patients received maintenance treatment, muscle strength, reflexes, vibration sense, and the Self-Evaluation Scale score significantly deteriorated over time. Lower MRC sumscore and absence of reflexes predicted a more progressive disease course. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that lower MRC sumscore and the absence of reflexes predict a more progressive disease course in patients with MMN.


Subject(s)
Motor Neuron Disease/physiopathology , Polyneuropathies/physiopathology , Adult , Aged , Cohort Studies , Cross-Sectional Studies , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged
2.
Brain Behav ; 7(5): e00632, 2017 05.
Article in English | MEDLINE | ID: mdl-28523213

ABSTRACT

OBJECTIVE: The main objective of this study was to evaluate the correlation between the distribution of brachial plexus magnetic resonance imaging (MRI) abnormalities and clinical weakness, and to evaluate the value of brachial plexus MRI in predicting disease course and response to treatment in multifocal motor neuropathy (MMN), Lewis-Sumner syndrome (LSS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). METHODS: Sixty-seven patients with an inflammatory neuropathy diagnosed at our tertiary referral center for neuromuscular diseases had undergone bilateral T2-weighted short tau inversion recovery (STIR) MRI of the brachial plexus. We obtained clinical follow-up data and scored all MRIs for abnormalities and the symmetry of their distribution. RESULTS: Brachial plexus MRI abnormalities were detected in 45% of the patients. An abnormal MRI did not predict disease course in terms of patterns of weakness, sensory disturbances or response to treatment. Within the spectrum of radiological abnormalities, asymmetrical clinical syndromes, MMN and LSS were significantly associated with asymmetrical radiological abnormalities, whereas symmetrical abnormalities predominated in CIDP (p < .001, phi 0.791). CONCLUSION: T2 STIR brachial plexus MRI abnormalities correspond with the distribution of neurological deficits in inflammatory neuropathies, but do not correlate with specific clinical characteristics, response to treatment or disease course.


Subject(s)
Brachial Plexus/diagnostic imaging , Magnetic Resonance Imaging/methods , Polyneuropathies/diagnosis , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/diagnosis , Adult , Aged , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Netherlands , Retrospective Studies
3.
Eur Radiol ; 27(5): 2216-2224, 2017 May.
Article in English | MEDLINE | ID: mdl-27655303

ABSTRACT

OBJECTIVES: To study disease mechanisms in multifocal motor neuropathy (MMN) with magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) of the median and ulnar nerves. METHODS: We enrolled ten MMN patients, ten patients with amyotrophic lateral sclerosis (ALS) and ten healthy controls (HCs). Patients underwent MRI (in a prone position) and nerve conduction studies. DTI and fat-suppressed T2-weighted scans of the forearms were performed on a 3.0T MRI scanner. Fibre tractography of the median and ulnar nerves was performed to extract diffusion parameters: fractional anisotropy (FA), mean (MD), axial (AD) and radial (RD) diffusivity. Cross-sectional areas (CSA) were measured on T2-weighted scans. RESULTS: Forty-five out of 60 arms were included in the analysis. AD was significantly lower in MMN patients (2.20 ± 0.12 × 10-3 mm2/s) compared to ALS patients (2.31 ± 0.17 × 10-3 mm2/s; p < 0.05) and HCs (2.31± 0.17 × 10-3 mm2/s; p < 0.05). Segmental analysis showed significant restriction of AD, RD and MD (p < 0.005) in the proximal third of the nerves. CSA was significantly larger in MMN patients compared to ALS patients and HCs (p < 0.01). CONCLUSIONS: Thickening of nerves is compatible with changes in the myelin sheath structure, whereas lowered AD values suggest axonal dysfunction. These findings suggest that myelin and axons are diffusely involved in MMN pathogenesis. KEY POINTS: • Diffusion magnetic resonance imaging provides quantitative information about multifocal motor neuropathy (MMN). • Diffusion tensor imaging allows non-invasive evaluation of the forearm nerves in MMN. • Nerve thickening and lowered diffusion parameters suggests myelin and axonal changes. • This study can help to provide insight into pathological mechanisms of MMN.


Subject(s)
Median Nerve/diagnostic imaging , Motor Neuron Disease/diagnostic imaging , Ulnar Nerve/diagnostic imaging , Adult , Aged , Amyotrophic Lateral Sclerosis/diagnostic imaging , Amyotrophic Lateral Sclerosis/physiopathology , Anisotropy , Case-Control Studies , Diffusion Magnetic Resonance Imaging/methods , Diffusion Tensor Imaging/methods , Female , Forearm/innervation , Humans , Magnetic Resonance Imaging/methods , Male , Median Nerve/physiopathology , Middle Aged , Motor Neuron Disease/physiopathology , Neural Conduction/physiology , Ulnar Nerve/physiopathology
4.
Muscle Nerve ; 54(6): 1133-1135, 2016 12.
Article in English | MEDLINE | ID: mdl-27571543

ABSTRACT

INTRODUCTION: Differentiating multifocal motor neuropathy (MMN) from amyotrophic lateral sclerosis (ALS) is important, as MMN is a difficult, but treatable disorder. METHODS: We studied peripheral nerve imaging techniques in differentiating MMN from ALS by measuring the cross-sectional area (CSA) of the median and ulnar nerves in the forearms using high resolution ultrasound (HRUS) and MRI. RESULTS: HRUS CSA values of the median nerve in the forearm (P = 0.002) and the ulnar nerve distal to the sulcus (P = 0.009) were significantly enlarged in patients with MMN. There was a positive correlation between CSA as measured with HRUS and MRI (Spearman rho 0.60; P < 0.001). CONCLUSIONS: Peripheral nerve imaging is a potentially powerful technique to distinguish MMN from ALS. Muscle Nerve, 2016 Muscle Nerve 54: 1133-1135, 2016.


Subject(s)
Amyotrophic Lateral Sclerosis/diagnostic imaging , Magnetic Resonance Imaging , Peripheral Nerves/diagnostic imaging , Peripheral Nerves/physiopathology , Polyneuropathies/diagnostic imaging , Ultrasonography , Adult , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged , Neural Conduction , Statistics, Nonparametric
5.
J Clin Immunol ; 34 Suppl 1: S112-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24728842

ABSTRACT

Multifocal motor neuropathy (MMN) is a rare inflammatory neuropathy characterized by progressive, asymmetric distal limb weakness and conduction block (CB). Clinically MMN is a pure motor neuropathy, which as such can mimic motor neuron disease. GM1-specific IgM antibodies are present in the serum of approximately half of all MMN patients, and are thought to play a key role in the immune pathophysiology. Intravenous immunoglobulin (IVIg) treatment has been shown to be effective in MMN in five randomized placebo-controlled trials. Despite long-term treatment with intravenous immunoglobulin (IVIg), which is efficient in the majority of patients, slowly progressive axonal degeneration and subsequent muscle weakness cannot be fully prevented. In this review, we will discuss the current understanding of the immune pathogenesis underlying MMN and how this may cause CB, available treatment strategies and future therapeutic targets.


Subject(s)
G(M1) Ganglioside/immunology , Immunoglobulins, Intravenous/therapeutic use , Immunotherapy/methods , Motor Neurons/immunology , Polyneuropathies/physiopathology , Animals , Autoantibodies/metabolism , Cell Communication , Humans , Immunoglobulin M/metabolism , Neural Conduction/drug effects , Polyneuropathies/immunology , Polyneuropathies/therapy , Randomized Controlled Trials as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...